DiscoverRCM Consultants - Medical Billing Marketing, RCM Automation, Data, and AI.
RCM Consultants - Medical Billing Marketing, RCM Automation, Data, and AI.
Claim Ownership

RCM Consultants - Medical Billing Marketing, RCM Automation, Data, and AI.

Author: Sean McSweeney

Subscribed: 5Played: 168
Share

Description

Podcast about how to run an effective RCM company, focusing on medical billing lead generation, RCM automation, technology, data, and analytics, including artificial intelligence for RCM. We also cover general medical billing management consulting and scalable process design. Written versions of these podcasts are typically available on our blog at https://voyanthealth.io/blog.
351 Episodes
Reverse
A prospect fills out your form on Tuesday morning, and the earliest slot on your calendar is Wednesday afternoon. By then, another company may already have them. If you're trying to grow your billing company, your medical billing lead response time may be quietly costing you deals you never knew you were competing for.This episode challenges the habit of making prospects wait, even when same-day calls are operationally hard. Sean explains why lost deals are so hard to measure, and shares the industry numbers that make the case for speed. The conversation also covers friction, gatekeepers, and what your lead response time says to buyers.What You'll Learn:How much does a same-day call really change your close rate compared with next-day?Why do so many prospects talk to your competitor before ever showing up to your call?Do you need to close on the first call to win the deal?How can you cut friction without losing the information you need to qualify leads?Fast, live access is one of the cheapest ways to improve results from the same marketing budget, so tighten your medical billing lead response time before you spend another dollar on leads.
Your prospect just heard a pitch from a startup with hundreds of millions in funding and a promise of zero humans. Should a medical billing AI pitch like that keep you up at night?In this final part of our series on competing with AI-native companies, we look at two heavily funded examples, one in revenue cycle management and one in claims administration. We challenge the hype, question the funding logic, and reveal what these companies' own pivots say about the model.What You'll Learn:Why did well-funded teams with elite investors struggle to make AI-native billing work?What does a "hybrid" model really mean when you look closely?Why does venture funding push startups toward the riskiest approach?How can a smaller company win deals against a competitor that can buy business?The takeaway: you don't need to fear medical billing AI startups, because a modular, iterative technology strategy built on strong operations is the stronger long-term play.
Your competitors are pitching "AI-native" platforms, and you're wondering whether your piecemeal approach to RCM automation can possibly keep up. Should you rip everything out and rebuild around one giant AI system?In part two of this series, Sean McSweeney challenges the idea that AI-native is automatically better. He explains why a modular approach to RCM automation can be lower risk, more flexible, and easier to improve as technology changes.What You'll Learn:Why a single AI-native platform can make implementation harder, riskier, and more expensiveWhether going modular means giving up unified, centralized dataWhat AI's blind spots mean for how much of your workflow you should hand overWhat a fully autonomous, self-correcting AI system would actually requireStart automating the pieces where AI works today, and expand your RCM automation iteratively instead of betting everything on a single platform.
Private equity keeps funding well-capitalized startups that promise a fully automated future, and you are left wondering whether your medical billing company can survive against an AI native RCM competitor with nine figures in the bank.Sean McSweeney challenges the fear and hype around AI native RCM platforms. He separates the investor pitch from operational reality and draws on his own early mistakes entering medical billing to explain why a company built from scratch may not be the unstoppable force it appears to be.What You'll Learn:What does AI native actually mean, and is it really all AI?Why do tech-first teams so often underestimate the complexity of billing and claims processing?How does building for yourself differ from selling one platform to everyone?What advantage might an existing operation have that a startup cannot buy?Competition from AI native RCM companies is real, but this episode makes the case that you do not need to panic about being wiped out overnight.
Cold Email Keys to Success
loading
Comments